Background and Aims: In aortic stenosis (AS), valvular calcification causes the aortic valve dysfunction.
Currently, no pharmacologic treatment is available for AS. Vitamin K dependent Matrix
Gla protein is known to inhibit vascular calcification in mice and recently, in the
small interventional proof of concept study in patients, vitamin K attenuated the
progression of AS. Here, we studied the effect of menaquinone 4 (MK4) on valvular
calcification in the hypercholesterolemic mouse model of AS.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Published online: August 05, 2019
EAS19-0670Identification
Copyright
© 2019 Published by Elsevier Inc.
